Federal Register / Vol. 80, No. 67 / Wednesday, April 8, 2015 / Notices 18867 

COLORADO 

Park County 

Tarryall Rural Historic Landscape, Cty. Rd. 

77, Mileposts 2.4 to 41.8, Jefferson, 

15000170 

San Juan County 

Sound Democrat Mill and Mine and Silver 

Queen Mine, (Mining Resources of San 

Juan County, Colorado MPS) Address 

Restricted, Silverton, 15000171 

MARYLAND 

Baltimore Independent city 

McDonogh Place Historic District, N. 

Broadway, E. Eager, McDonogh & E. Chase 

Sts., Baltimore, 15000172 

Charles County 

Mallows Bay—Widewater Historic and 

Archeological District, Off Charles County 

shoreline at Sandy Pt., Nanjemoy, 

15000173 

MISSOURI 

St. Louis Independent city 

Woodward and Tierman Printing Company 

Building, 1519 Tower Grove Ave., St. 

Louis, 15000174 

NEW HAMPSHIRE 

Coos County 

Burgess, George E., School—Notre Dame 

High Schol, 411 School St., Berlin, 

15000175 

NEW JERSEY 

Sussex County 

Waterloo Village (Boundary Increase), 

Musconetcong R. & Cty. Rd. 604, Byram 

Township, 15000176 

NEW YORK 

Bronx County 

Crotona Play Center, 1700 Fulton Ave., 

Bronx, 15000177 

Suffolk County 

Sylvester Manor, 80 N. Ferry Rd., Shelter 

Island, 15000178 

NORTH CAROLINA 

Ashe County 

Ashe County Memorial Hospital, (Ashe 

County, North Carolina, c. 1799–1955 

MPS) 410 McConnell St., Jefferson, 

15000179 

Beaufort County 

Belhaven Commercial Historic District, 260– 

292 E. Main & 246–288, 251–279 Pamlico 

Sts., Belhaven, 15000180 

Guilford County 

Willis, James H. and Anne B., House, 707 

Blair St., Greensboro, 15000181 

Harnett County 

Erwin Commercial Historic District, 100 

Denim Drive, 101–127 E. H & 103–111 S. 

13th Sts., Erwin, 15000182 

Mecklenburg County 

Outen, R.F., Pottery, 430 Jefferson St., 

Matthews, 15000183 

OHIO 

Hamilton County 

United States Post Office and Court House, 

100 E. 5th St., Cincinnati, 15000184 

Ottawa County 

Perry’s Victory and International Peace 

Memorial (Boundary Increase), 93 

Delaware Ave., Put-in-Bay, 15000185 

TENNESSEE 

Grundy County 

Christ Episcopal Church, 530 10th St., Tracy 

City, 15000186 

Shelby County 

One Hundred North Main Building, 100 N. 

Main St. Mall, Memphis, 15000187 

WEST VIRGINIA 

Marion County 

Dunbar School, 103 High St., Fairmont, 

15000188 

WISCONSIN 

Sheboygan County 

Prange, Eliza, House, 605 Erie Ave., 

Sheboygan, 15000189 

WYOMING 

Teton County 

Hardeman Barns, 5450 W. WY 22, Wilson, 

15000190 

[FR Doc. 2015–08007 Filed 4–7–15; 8:45 am] 

BILLING CODE 4312–51–P 

INTERNATIONAL TRADE 

COMMISSION 

Public Availability of FY 2013 Service 

Contract Inventory Analysis, FY 2014 

Service Contract Inventory, and FY 

2014 Service Contract Inventory 

Planned Analysis 

AGENCY: U.S. International Trade 

Commission. 

ACTION: Notice. 

SUMMARY: In accordance with Section 

743 of Division C of the Consolidated 

Appropriations Act of 2010 (Pub. L. 

111–117), the U.S. International Trade 

Commission is publishing this notice to 

advise the public of the availability of 

the FY 2013 Service Contract Inventory 

Analysis, the FY 2014 Service Contract 

Inventory, and the FY 2014 Service 

Contract Inventory Planned Analysis. 

The FY 2013 inventory analysis 

provides information on specific service 

contract actions that were analyzed as 

part of the FY 2013 inventory. The 2014 

inventory provides information on 

service contract actions over $25,000 

which were made in FY 2014. The 

inventory information is organized by 

function to show how contracted 

resources are distributed throughout the 

agency. The inventory has been 

developed in accordance with guidance 

issued on November 5, 2010 by the 

Office of Management and Budget’s 

Office of Federal Procurement Policy 

(OFPP). OFPP’s guidance is available at 

http://www.whitehouse.gov/sites/

default/files/omb/procurement/memo/

service-contract-inventories-guidance11052010.pdf. The FY 2014 inventory 

planned analysis provides information 

on which functional areas will be 

reviewed by the agency. The United 

States International Trade Commission 

has posted its FY 2014 inventory, FY 

2014 planned analysis, and FY 2013 

inventory analysis at the following link: 

http://www.usitc.gov/procurement/. 

FOR FURTHER INFORMATION CONTACT: 

Questions regarding the service contract 

inventory should be directed to Debra 

Bridge, U.S. International Trade 

Commission, Office of Procurement, 500 

E Street SW., Washington, DC 20436, or 

at 202–205–2004 or debra.bridge@

usitc.gov. 

By order of the Commission. 

Dated: April 3, 2015. 

Lisa R. Barton, 

Secretary to the Commission. 

[FR Doc. 2015–08050 Filed 4–7–15; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–411N] 

Controlled Substances: Proposed 

Adjustments to the Aggregate 

Production Quotas for Difenoxin, 

Diphenoxylate (for conversion), and 

Marijuana 

AGENCY: Drug Enforcement 

Administration, Department of Justice. 

ACTION: Notice with request for 

comments. 

SUMMARY: The Drug Enforcement 

Administration is proposing to adjust 

the established 2015 aggregate 

production quota for difenoxin, 

diphenoxylate (for conversion), and 

marijuana which are schedule I and II 

controlled substances under the 

Controlled Substances Act. 

DATES: Interested persons may file 

written comments on this notice in 

accordance with 21 CFR 1303.13. 

Electronic comments must be 

submitted, and written comments must 

be postmarked, on or before May 8, 


asabaliauskas on DSK5VPTVN1PROD with NOTICES
18868 Federal Register / Vol. 80, No. 67 / Wednesday, April 8, 2015 / Notices 

2015. Commenters should be aware that 

the electronic Federal Docket 

Management System will not accept 

comments after 11:59 p.m. Eastern Time 

on the last day of the comment period. 

ADDRESSES: To ensure proper handling 

of comments, please reference ‘‘Docket 

No. DEA–411N’’ on all correspondence, 

including any attachments. The Drug 

Enforcement Administration encourages 

that all comments be submitted 

electronically through the Federal 

eRulemaking Portal which provides the 

ability to type short comments directly 

into the comment field on the Web page 

or attach a file for lengthier comments. 

Please go to http://www.regulations.gov 

and follow the online instructions at 

that site for submitting comments. Upon 

completion of your submission you will 

receive a Comment Tracking Number for 

your comment. Please be aware that 

submitted comments are not 

instantaneously available for public 

view on Regulations.gov. If you have 

received a Comment Tracking Number, 

your comment has been successfully 

submitted and there is no need to 

resubmit the same comment. Paper 

comments that duplicate electronic 

submissions are not necessary and are 

discouraged. Should you wish to mail a 

paper comment in lieu of an electronic 

comment, it should be sent via regular 

or express mail to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/ODXL, 8701 

Morrissette Drive, Springfield, Virginia 

22152. 

FOR FURTHER INFORMATION CONTACT: 

Imelda L. Paredes, Office of Diversion 

Control, Drug Enforcement 

Administration; Mailing Address: 8701 

Morrissette Drive, Springfield, Virginia 

22152, Telephone (202) 598–6812. 

SUPPLEMENTARY INFORMATION: 

Posting of Public Comments 

Please note that all comments 

received in response to this docket are 

considered part of the public record. 

They will, unless reasonable cause is 

given, be made available by the Drug 

Enforcement Administration for public 

inspection online at http://

www.regulations.gov. Such information 

includes personal identifying 

information (such as your name, 

address, etc.) voluntarily submitted by 

the commenter. The Freedom of 

Information Act applies to all comments 

received. If you want to submit personal 

identifying information (such as your 

name, address, etc.) as part of your 

comment, but do not want it to be 

posted online or made available in the 

public docket, you must include the 

phrase ‘‘PERSONAL IDENTIFYING 

INFORMATION’’ in the first paragraph 

of your comment. You must also place 

all the personal identifying information 

you do not want made publicly 

available in the first paragraph of your 

comment and identify what information 

you want redacted. 

If you want to submit confidential 

business information as part of your 

comment, but do not want it to be made 

publicly available, you must include the 

phrase ‘‘CONFIDENTIAL BUSINESS 

INFORMATION’’ in the first paragraph 

of your comment. You must also 

prominently identify confidential 

business information to be redacted 

within the comment. 

Comments containing personal 

identifying information and confidential 

business information identified and 

located as directed above will generally 

be made available in redacted form. If a 

comment has so much confidential 

business information or personal 

identifying information that it cannot be 

effectively redacted, all or part of that 

comment may not be made publicly 

available. Comments posted to http://

www.regulations.gov may include any 

personal identifying information (such 

as name, address, and phone number) 

included in the text of your electronic 

submission that is not identified as 

directed above as confidential. 

An electronic copy of this document 

is available at http://

www.regulations.gov for easy reference. 

Legal Authority 

The Drug Enforcement 

Administration (DEA) implements and 

enforces titles II and III of the 

Comprehensive Drug Abuse Prevention 

and Control Act of 1970, as amended. 21 

U.S.C. 801–971. Titles II and III are 

referred to as the ‘‘Controlled 

Substances Act’’ and the ‘‘Controlled 

Substances Import and Export Act,’’ 

respectively, and are collectively 

referred to as the ‘‘Controlled 

Substances Act’’ or the ‘‘CSA’’ for the 

purpose of this action. The DEA 

publishes the implementing regulations 

for these statutes in title 21 of the Code 

of Federal Regulations (CFR), chapter II. 

The CSA and its implementing 

regulations are designed to prevent, 

detect, and eliminate the diversion of 

controlled substances and listed 

chemicals into the illicit market while 

providing for the legitimate medical, 

scientific, research, and industrial needs 

of the United States. Controlled 

substances have the potential for abuse 

and dependence and are controlled to 

protect the public health and safety. 

Section 306 of the CSA (21 U.S.C. 

826) requires the Attorney General to 

establish aggregate production quotas 

for each basic class of controlled 

substance listed in schedules I and II 

each year. The Attorney General has 

delegated this function to the 

Administrator of the DEA, 28 CFR 

0.100. 

Background 

The DEA established the initial 2015 

aggregate production quotas and 

assessments of annual need on 

September 8, 2014 (79 FR 53216). That 

notice stipulated that, as provided for in 

21 CFR 1303.13, all aggregate 

production quotas and assessments of 

annual need are subject to adjustment. 

Based on unanticipated medical, 

scientific, research, and industrial needs 

of the United States the DEA proposes 

to adjust the established 2015 aggregate 

production quotas for the schedule I and 

II controlled substances difenoxin, 

diphenoxylate (for conversion), and 

marijuana to be manufactured in the 

United States in 2015. The adjustment 

is necessary to provide for the estimated 

medical, scientific, research, and 

industrial needs of the United States, 

lawful export requirements, and the 

establishment and maintenance of 

reserve stocks. 

In proposing the adjustment, the 

Administrator has taken into account 

the following criteria in accordance 

with 21 CFR 1303.13: (1) Changes in 

demand for the basic class, changes in 

the national rate of net disposal for the 

class, and changes in the rate of net 

disposal by the registrants holding 

individual manufacturing quotas for the 

class; (2) whether any increased demand 

or changes in the national and/or 

individual rates of net disposal are 

temporary, short term, or long term; (3) 

whether any increased demand for that 

class can be met through existing 

inventories, increased individual 

manufacturing quotas, or increased 

importation, without increasing the 

aggregate production quota; (4) whether 

any decreased demand will result in 

excessive inventory accumulation by all 

persons registered to handle the class; 

and (5) other factors affecting the 

medical, scientific, research, and 

industrial needs of the United States 

and lawful export requirements, as the 

Administrator finds relevant. 

Analysis for Adjusting the Established 

2015 Aggregate Production Quota for 

Difenoxin and Diphenoxylate (for 

Conversion) 

Since the establishment of the initial 

2015 aggregate production quotas, the 

DEA has received requests from DEA 

registered manufacturers to manufacture 

difenoxin and diphenoxylate (for 

conversion) to support the manufacture 


asabaliauskas on DSK5VPTVN1PROD with NOTICES
Federal Register / Vol. 80, No. 67 / Wednesday, April 8, 2015 / Notices 18869 

1 Difenoxin (schedule I) is the active 

pharmaceutical ingredient in the diarrhea 

preparation (schedule V). 

of prescription drug products approved 

by the Food and Drug Administration 

(FDA) for the treatment of chronic 

diarrhea and for the treatment of 

diarrhea associated with irritable bowel 

syndrome (IBS).1 These FDA approved 

products have not been manufactured 

since 2009 due to FDA-regulated 

manufacturing issues and there is no 

existing generic or therapeutic 

equivalent. 

Analysis for Adjusting the Established 

2015 Aggregate Production Quota for 

Marijuana 

Since the establishment of the initial 

2015 aggregate production quotas, the 

DEA has received notification from DEA 

registered manufacturers that research 

and product development involving 

cannabidiol, is increasing beyond that 

previously anticipated for 2015. The 

associated product development 

activities are related to process 

validation and commercialization 

activities, including qualification 

activities related to potential U.S. Food 

and Drug Administration submission 

support. 

Additionally, the DEA has also 

received notification from the National 

Institute on Drug Abuse (NIDA) that it 

required additional supplies of 

marijuana to be manufactured in 2015 to 

provide for ongoing and anticipated 

research efforts involving marijuana. 

NIDA is a component of the National 

Institutes of Health and the U.S. 

Department of Health and Human 

Services which oversees the cultivation, 

production and distribution of researchgrade marijuana on behalf of the United 

States Government, pursuant to the 

Single Convention on Narcotic Drugs 

(March 30, 1961, 18 UST 1407). 

The Administrator, therefore, 

proposes to adjust the 2015 aggregate 

production quotas for difenoxin, 

diphenoxylate (for conversion), and 

marijuana, expressed in grams of 

anhydrous acid or base, as follows: 

Basic classschedule I 

Previously 

established 

2015 quota 

Adjusted 2015 

quota 

Difenoxin ... 50 g 9,000 g 

Marijuana .. 125,000 g 400,000 g 

Basic classschedule II 

Previously 

established 

2015 quota 

Adjusted 2015 

quota 

Diphenoxylate (for conversion).Zero ............ 75,000 g 

Dated: April 1, 2015. 

Michele M. Leonhart, 

Administrator. 

[FR Doc. 2015–08042 Filed 4–7–15; 8:45 am] 

BILLING CODE 4410–09–P 

NATIONAL AERONAUTICS AND 

SPACE ADMINISTRATION 

[Notice (15–026)] 

Notice of Intent To Grant a Partially 

Exclusive License 

AGENCY: National Aeronautics and 

Space Administration. 

ACTION: Notice of Intent to Grant 

Partially Exclusive License. 

SUMMARY: This notice is issued in 

accordance with 35 U.S.C. 209(e) and 37 

CFR 404.7(a)(1)(i). NASA hereby gives 

notice of its intent to grant a partially 

exclusive license in the United States to 

practice the invention described and 

claimed in U.S. Patent No. 7,086,593 B2 

titled ‘‘Magnetic Field Response 

Measurement Acquisition System,’’ 

NASA Case No. LAR–16908–1; U.S. 

Patent No. 7,159,774 B2 titled 

‘‘Magnetic Field Response Measurement 

Acquisition System,’’ NASA Case No. 

LAR–17280–1; U.S. Patent No. 

7,075,295 B2 titled ‘‘Magnetic Field 

Response Sensor for Conductive 

Media,’’ NASA Case No. LAR–16571–1; 

U.S. Patent No. 7,589,525 B2 titled 

‘‘Magnetic Field Response Sensor for 

Conductive Media,’’ NASA Case No. 

LAR–16571–2; U.S. Patent No. 

7,759,932 B2 titled ‘‘Magnetic Field 

Response Sensor for Conductive 

Media,’’ NASA Case No. LAR–16571–3; 

U.S. Patent No. 8,430,327 B2 titled 

‘‘Wireless Sensing System Using OpenCircuit, Electrically-Conductive SpiralTrace Sensor,’’ NASA Case No. LAR– 

17294–1; U.S. Patent No. 7,683,797 B2 

titled ‘‘Damage Detection/Locating 

System Providing Thermal Protection,’’ 

NASA Case No. LAR–17295–1; U.S. 

Patent No. 7,902,815 B2 titled ‘‘Wireless 

System and Method for Collecting 

Motion and Non-Motion Related Data of 

a Rotating System,’’ NASA Case No. 

LAR–17433–1; U.S. Patent No. 

8,042,739 B2 titled ‘‘Wireless Tamper 

Detection Sensor and Sensing System,’’ 

NASA Case No. LAR–17444–1; U.S. 

Patent No. 7,711,509 B2 titled ‘‘Method 

of Calibrating a Fluid-Level 

Measurement System,’’ NASA Case No. 

LAR–17480–1; U.S. Patent No. 

7,814,786 B2 titled ‘‘Wireless Sensing 

System for Non-Invasive Monitoring of 

Attributes of Contents in a Container,’’ 

NASA Case No. LAR–17488–1; U.S. 

Patent No. 8,673,649 B2 titled ‘‘Wireless 

Chemical Sensor and Sensing Method 

for Use Therewith,’’ NASA Case No. 

LAR–17579–1; U.S. Patent Application 

No. 14/215,793 titled ‘‘Wireless 

Chemical Sensor and Sensing Method 

for Use Therewith,’’ NASA Case No. 

LAR–17579–2; U.S. Patent No. 

8,167,204 B2 titled ‘‘Wireless Damage 

Location Sensing System,’’ NASA Case 

No. LAR–17593–1; U.S. Patent No. 

8,179,203 B2 titled ‘‘Wireless Electrical 

Device Using Open-Circuit Elements 

Having No Electrical Connections,’’ 

NASA Case No. LAR–17711–1; U.S. 

Patent Application No. 14/193,861 titled 

‘‘Wireless Temperature Sensing Having 

No Electrical Connections and Sensing 

Method for Use Therewith,’’ NASA Case 

No. LAR–17747–1–CON; U.S. Patent 

Application No. 13/796,626 titled 

‘‘Method of Mapping Anomalies in 

Homogenous Material,’’ NASA Case No. 

LAR–17848–1 to GLSEQ, LLC having its 

principal place of business in Owens 

Cross Roads, Alabama. The fields of use 

may be limited to, but not necessarily be 

limited to, safety related and non-safety 

related instrumentation and control 

systems for nuclear facilities, including 

advanced safety related and non-safety 

related instrumentation systems for 

severe accident monitoring within 

nuclear power plants and nuclear 

storage facilities. The patent rights in 

these inventions have been assigned to 

the United States of America as 

represented by the Administrator of the 

National Aeronautics and Space 

Administration. The prospective 

partially exclusive license will comply 

with the terms and conditions of 35 

U.S.C. 209 and 37 CFR 404.7. 

DATES: The prospective partially 

exclusive license may be granted unless, 

within fifteen (15) days from the date of 

this published notice, NASA receives 

written objections including evidence 

and argument that establish that the 

grant of the license would not be 

consistent with the requirements of 35 

U.S.C. 209 and 37 CFR 404.7. 

Competing applications completed and 

received by NASA within fifteen (15) 

days of the date of this published notice 

will also be treated as objections to the 

grant of the contemplated partially 

exclusive license. 

Objections submitted in response to 

this notice will not be made available to 

the public for inspection and, to the 

extent permitted by law, will not be 

released under the Freedom of 

Information Act, 5 U.S.C. 552. 

ADDRESSES: Objections relating to the 

prospective license may be submitted to 

Patent Counsel, Office of Chief Counsel, 

NASA Langley Research Center, MS 30, 


asabaliauskas on DSK5VPTVN1PROD with NOTICES